Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biased coin ED90 analysis of cyclopropofol for anxious vs non-anxious patients undergoing painless gastroscopy
ChiCTR2400080124Phase 4Recruiting
- Sponsor
- Beijing Shijitan Hospital
- Start
- Jan 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in anxiety disorder (2 arms), sponsored by Beijing Shijitan Hospital. Primary endpoints: Cyclopropofol dose and Ramsay sedation score. Started Jan 2024; status: recruiting.
02
Drugs
ciprofol
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2400080124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080124.